Brief: Marker Therapeutics Reports Q2 2022 Operating And Financial Results

Marker Therapeutics

11/08/2022 22:35

Aug 11 (Reuters) - Marker Therapeutics Inc  MRKR.O :
    * MARKER THERAPEUTICS REPORTS Q2 2022 OPERATING AND
FINANCIAL
RESULTS
    * MARKER THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.11
    * MARKER THERAPEUTICS - ON AUGUST 10, IMPLEMENTED CHANGES TO
COMPANY'S ORGANIZATIONAL STRUCTURE AS PART OF AN OPERATIONAL
COST REDUCTION PLAN
    * MARKER THERAPEUTICS INC - REDUCED HEADCOUNT IN ITS GENERAL
AND
ADMINISTRATIVE FUNCTION BY APPROXIMATELY 23.5%
    * MARKER THERAPEUTICS INC - ESTIMATES THAT SEVERANCE AND
TERMINATION-RELATED COSTS WILL TOTAL APPROXIMATELY $0.7 MILLION
AND WILL BE RECORDED IN Q3 OF 2022

Source text for Eikon:  ID:nGNX4n18fc 
Further company coverage:  MRKR.O 

 ((Reuters.Briefs@thomsonreuters.com;))